Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Labaki

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|June 14, 2021
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumorsEmre Yekedüz, Dario Trapani, Wenxin Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR TrialThomas Denize, Subrina Farah, Alessia Cimadamore, et al.
Human Vaccines & Immunotherapeutics|November 28, 2025
Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatmentHuijing Xue, Troy J Kemp, Chenglei Li, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell CarcinomaSeunghun Han, Sabrina Y Camp, Hoyin Chu, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Implementing a context-augmented large language model to guide precision cancer medicineHyeji Jun, Yutaro Tanaka, Shreya Johri, et al.
European Urology Open Science|March 18, 2024
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell CarcinomaSeung Hun Han, Sabrina Y Camp, Hoyin Chu, et al.
The Lancet. Oncology|December 13, 2021
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker studyVivek Naranbhai, Mathias Viard, Michael Dean, et al.
Human Vaccines & Immunotherapeutics|October 14, 2025
Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatmentChristine M Dang, Troy J Kemp, Nancy Roche, et al.
Cell Reports. Medicine|September 20, 2023
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesJackson Nyman, Thomas Denize, Ziad Bakouny, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesJackson Nyman, Thomas Denize, Ziad Bakouny, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|June 14, 2021
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumorsEmre Yekedüz, Dario Trapani, Wenxin Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR TrialThomas Denize, Subrina Farah, Alessia Cimadamore, et al.
Human Vaccines & Immunotherapeutics|November 28, 2025
Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatmentHuijing Xue, Troy J Kemp, Chenglei Li, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell CarcinomaSeunghun Han, Sabrina Y Camp, Hoyin Chu, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Implementing a context-augmented large language model to guide precision cancer medicineHyeji Jun, Yutaro Tanaka, Shreya Johri, et al.
European Urology Open Science|March 18, 2024
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell CarcinomaSeung Hun Han, Sabrina Y Camp, Hoyin Chu, et al.
The Lancet. Oncology|December 13, 2021
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker studyVivek Naranbhai, Mathias Viard, Michael Dean, et al.
Human Vaccines & Immunotherapeutics|October 14, 2025
Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatmentChristine M Dang, Troy J Kemp, Nancy Roche, et al.
Cell Reports. Medicine|September 20, 2023
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesJackson Nyman, Thomas Denize, Ziad Bakouny, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesJackson Nyman, Thomas Denize, Ziad Bakouny, et al.
Pageof 8